FDA meeting rescheduled
This article was originally published in The Tan Sheet
Executive Summary
Manufacturing Subcommittee of the Advisory Committee on Pharmaceutical Science, which was slated to meet March 21, will instead combine that agenda with next scheduled meeting May 21-22. Inaugural meeting of the subcommittee was cancelled due to war in Iraq; FDA was expected to outline its progress on the "Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach" initiative (1"The Tan Sheet" Sept. 2, 2002, p. 13)...